Dharmisha Chauhan, MPharm, The Royal Marsden NHS Foundation Trust, London, UK, lists the data highlights from ESMO 2019, including the BEACON CRC trial (NCT02928224), updates in the melanoma and sarcoma fields, and new renal cancer guidelines.This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.